Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.
Message: Even after more than 50 MMPl-icenses we still have the same share price trouble
Did you know?
You can earn activity points by filling your profile with information about yourself (what city you live in, your favorite team, blogs etc.)
Re: Even after more than 50 MMPl-icenses we still have the same share price trouble
Also, the market remembers the last 10Q in which a company paid $250K for a license. License signings will no longer cause any blips in the SP unless the 10Qs start showing some meaningful revenue from license signings.